Delivery Order SPE2DB20D3303-SPE2DB25FZ2F0

Award Date 3/3/25
Potential Completion Date 3/4/25
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML, awarded to prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,741.68 Firm Fixed Price contract was issued by the Defense Logistics Agency (DLA), a defense agency, as a Delivery Order. The contract has an ultimate completion date of October 31, 2024 and does not have a set-aside designation, indicating open competition....
The federal contract award is for the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML, awarded to the prime contractor Amerisourcebergen Drug Corp. The $1,741.68 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, on September 22, 2022, with a final completion date of September 23, 2022. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that provides a...
This federal contract award is for the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML, awarded to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,059.28, is a delivery order issued by the Defense Logistics Agency (DLA), a defense agency, for the supply of this medication. The contract is a firm fixed price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $3,483.36 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 8, 2024. The contract has an ultimate completion date of November 12, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,741.68 and a completion date of September 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This federal contract award is for the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML, awarded to prime contractor Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,081.92 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company...
The federal contract award is for the delivery of the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The $6,005.32 firm fixed price delivery order was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, has a completion date of May 17, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order, valued at $3,190.83, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract has a period of performance through May 31, 2024 and does not include a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award value is $2,056.26 with a firm fixed price and an ultimate completion date of September 30, 2022. The contract is a delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,612.52 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 9, 2024, with an ultimate completion date of September 10, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FZ2F0
    Delivery Order

This federal contract award is for the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price of $7,094.36 and a completion date of March 4, 2025. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 6/2/25, 10:01 AM